STEVEN
63 years old
CKD Stage 4, hypertension, type 2 diabetes with recurrent hyperkalemia
“I’m worried about whether my current treatment plan will keep my potassium levels under control. I also struggle with maintaining a diet for my conditions.”
See Steven’s treatment journey
- Previously prescribed SPS episodically to address recurrent hyperkalemic events, and recommended to dietitian for low-K+ diet
- Experienced GI side effects from SPS
- Recent lab results show another hyperkalemia occurrence within 3 months, with a serum K+ level of 5.7 mEq/L
PRESCRIBED LOKELMA:
Achieved and maintained normokalemia for 1 year with continued treatment and without the requirement of low-K+ diet modification
Appreciated that LOKELMA is tasteless and odorless
Individual is a hypothetical patient, not an actual patient.
CKD=chronic kidney disease; GI=gastrointestinal; SPS=sodium polystyrene sulfonate.
SOFIA
58 years old
CKD Stage 3b, type 2 diabetes, hypertension with recurrent hyperkalemia
“It’s difficult for me to manage all my conditions and dietary restrictions. I fear what might come next.”
See Sofia’s treatment journey
- Patient has difficulty adhering to low-K+ diet in addition to diabetes diet
- Physician previously reduced her RAAS inhibitor dose to further manage her hyperkalemia
- Recent lab results show that the patient is still hyperkalemic, with serum K+ levels of 5.5 mEq/L
PRESCRIBED LOKELMA:
Achieved and maintained normokalemia for 1 year with continued use and without the requirement of low-K+ diet modification
Guideline-recommended RAAS inhibitor use was reinitiated
Individual is a hypothetical patient, not an actual patient.
CKD=chronic kidney disease; RAAS=renin-angiotensin-aldosterone system.